Baxter Int'l (NYSE: BAX) announced that it has entered into a definitive agreement to sell its two commercially marketed vaccines ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE